Endoluminal Drug Applicator and Method of Treating Diseased Vessels of the Body

• US 20130297003A1
• Filed: 01/13/2012
• Published: 11/07/2013
• Est. Priority Date: 01/13/2011
• Status: Abandoned Application

• Current Assignee: Innovia LLC
• Original Assignee: Innovia LLC
• Inventors: Pinchuk, Leonard
• Application Number:
  US13/979,403
• Publication Number:
  US 20130297003A1
• Time in Patent Office: Days
• US Class Current: 623/1.12
• CPC Class Codes: A61F 2/07 Stent-grafts
• CPC Class Codes: A61F 2/90 characterised by a net-like or mesh-like structure
• CPC Class Codes: A61F 2/95 Instruments specially adapted for placement or removal of stents or stent-grafts
• CPC Class Codes: A61F 2002/075 the stent being loosely attached to the graft material, e.g. by stitching
• CPC Class Codes: A61F 2250/0067 Means for introducing or releasing pharmaceutical products into the body
• CPC Class Codes: A61M 2025/0681 Systems with catheter and outer tubing, e.g. sheath, sleeve or guide tube
• CPC Class Codes: A61M 2025/1081 having sheaths or the like for covering the balloon but not forming a permanent part of the balloon, e.g. retractable, dissolvable or tearable sheaths
• CPC Class Codes: A61M 25/104 used for angioplasty
• CPC Class Codes: A61P 25/06 Antimigraine agents
• CPC Class Codes: A61P 43/00 Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Abstract

A stent-graft is coupled to an elongate flexible member at or near the distal end of the flexible member and configurable in both a collapsed configuration and an expanded configuration. The stent-graft includes an expandable stent fixed to the flexible member. A portion of the expandable stent defines a generally tubular structure in its expanded configuration. A porous polymeric mesh interfaces circumferentially about the portion of the stent defines a generally tubular structure. The mesh is expandable with the stent and carries at least one therapeutic agent. When the stent-graft is in its expanded configuration and contacts the treatment site, the at least one therapeutic agent is transferred to the treatment site by operation of contact between the stent-graft and the treatment site. The mesh can define distal and proximal openings that allow for fluid flow through the stent-graft when the stent-graft is in the expanded configuration.

Claims

1. An apparatus for delivering a therapeutic agent to a treatment site of a vessel, valve, duct or bowel, the apparatus comprising:

a) a first elongate flexible member having a distal end; and

b) a stent-graft coupled to said flexible member at or near the distal end of said flexible member and configurable from a collapsed configuration to an expanded configuration, said stent-graft including,

i) an expandable stent fixed to said flexible member, wherein a portion of said expandable stent defines a generally tubular structure in said expanded configuration,

ii) a porous polymeric mesh that interfaces circumferentially about said portion of said stent and is expandable with said stent, and

iii) at least one therapeutic agent carried by said mesh, wherein when said stent-graft is in said expanded configuration and contacts the treatment site, said at least one therapeutic agent is transferred to the treatment site by operation of contact between said stent-graft and the treatment site.

2. An apparatus according to claim 1, wherein:

said mesh defines distal and proximal openings that allow for fluid flow through said stent-graft when said stent-graft is in said expanded configuration.

3. An apparatus according to claim 1, wherein:

said at least one therapeutic agent is selected from the group consisting of an antiproliferative drug, an antimitotic drug, and an antimigration drug.

4. An apparatus according to claim 1, wherein:

said first elongate flexible member is a guidewire.

5. An apparatus according to claim 1, wherein:

said first elongate flexible member is a first catheter.

6. An apparatus according to claim 5, further comprising:

a second catheter that defines a lumen that receives said first catheter, said first catheter longitudinally displaceable within the lumen of said second catheter, wherein said stent-graft is supported on a distal portion of said first catheter that extends distally beyond the distal end of said second catheter.

7. An apparatus according to claim 6, wherein:

said stent has a distal end and a proximal end, the distal end of said stent fixed at or near the distal end of said first catheter, and the proximal end of said stent fixed to the distal end of said second catheter.

8. An apparatus according to claim 7, wherein:

said stent-graft is configured in said expanded configuration by moving said first catheter proximally relative to said second catheter, and said stent-graft is configured in said collapsed configuration by moving said first catheter distally relative to said second catheter.

9. An apparatus according to claim 5, further comprising:

a sheath that covers that said first catheter, said first catheter longitudinally displaceable within said sheath, wherein said stent-graft is supported in its collapsed configuration within a distal portion of said sheath and extends distally beyond the distal end of said first catheter.

10. An apparatus according to claim 9, wherein:

said stent has a distal end and a proximal end, the distal end of said stent not attached to any structure, and the proximal end of said stent fixed to the distal end of said first catheter.

11. An apparatus according to claim 10, wherein:

said stent-graft is configured in said expanded configuration by moving said sheath proximally relative to said first catheter, and said stent-graft is configured in said collapsed configuration by moving said sheath distally relative to said first catheter.

12. An apparatus according to claim 5, further comprising:

a balloon catheter longitudinally displaceable within the lumen of said first catheter, said balloon catheter having a distal end; and

a balloon fixed at said distal end of said balloon catheter.

13. An apparatus according to claim 12, wherein:

said balloon has a first position in which said balloon is expanded and located distal said stent-graft.

14. An apparatus according to claim 13, wherein:

said balloon has a second position in which said balloon is expanded and located within said stent-graft.

15. An apparatus according to claim 1, further comprising:

c) a second elongate flexible member having a distal end; and

d) a generally tubular porous filter element with an open distal end that is deployed from the distal end of said second elongate member, said porous filter element having a collapsed configuration and an expanded configuration, wherein at least a portion of said filter element is adapted to contact a vessel wall in its expanded configuration and block emboli from flowing into one or more vessels.

16. An apparatus according to claim 15, wherein:

said second elongate flexible member and said filter element allow for longitudinal displacement of the first elongate flexible member through the interior space of said filter element in its expanded configuration for positioning of said first elongate flexible member distally relative to said filter element.

17. An apparatus according to claim 15, wherein:

said filter element is sized to cover a branch to at least one vessel disposed proximally from a contact point where said filter element contacts the vessel wall in its expanded configuration in order to block emboli from flowing into said branch.

18. An apparatus according to claim 15, wherein:

said filter element has a self-expanding element that self-expands to a configuration where a portion of the porous filter element contacts the vessel wall.

19. An apparatus according to claim 15, wherein:

said filter element has a closed proximal end that captures emboli.

20. An apparatus according to claim 15, wherein:

said filter element has an open proximal end that allows emboli to escape by flowing out the open proximal end.

21. An apparatus according to claim 15, wherein:

said filter element is adapted to contact the wall of the ascending aorta and block emboli from reaching the arteries that feed the brain.

22. A surgical method for delivering at least one therapeutic agent to a treatment site of a vessel, valve, duct or bowel, the method comprising:

a) providing the apparatus of claim 1; and

b) positioning the apparatus of claim 1 such that said stent-graft is located at the treatment site in said expanded configuration and contacts the treatment site, whereby said at least one therapeutic agent is transferred to the treatment site by operation of contact between said stent-graft and the treatment site.

23. A surgical method according to claim 22, wherein:

said mesh defines distal and proximal openings that allow for fluid flow through said stent-graft when said stent-graft is in said expanded configuration.

24. A surgical method according to claim 22, wherein:

said at least one therapeutic agent is selected from the group consisting of an antiproliferative drug, an antimitotic drug, and an antimigration drug.

25. A surgical method according to claim 1, further comprising:

c) expanding a balloon within said stent-graft in its expanded configuration while said stent-graft is contacting the treatment site.

26. A surgical method for delivering at least one therapeutic agent to a treatment site of a vessel, valve, duct or bowel, the method comprising:

a) providing a stent-graft configurable in both a collapsed configuration and an expanded configuration, said stent-graft including,

i) an expandable stent, wherein a portion of said expandable stent defines a generally tubular structure in said expanded configuration,

ii) a porous polymeric mesh that interfaces circumferentially about said portion of said stent and expandable with said stent, and

iii) at least one therapeutic agent carried by said mesh; and

b) locating said stent-graft at the treatment site in said expanded configuration such that it contacts the treatment site, whereby said at least one therapeutic agent is transferred to the treatment site by operation of contact between said stent-graft and the treatment site, wherein said mesh defines distal and proximal openings that allow for fluid flow through said stent-graft when said stent-graft is in said expanded configuration.

27. A surgical method according to claim 26, wherein:

said at least one therapeutic agent is selected from the group consisting of an antiproliferative drug, an antimitotic drug, and an antimigration drug.

28. A surgical method according to claim 26, further comprising:

c) expanding a balloon within said stent-graft in its expanded configuration while said stent-graft is contacting the treatment site.